Phase I Double-blind, Placebo-controlled Study of AZD7442
Clinical trial NCT04896541 · COMPLETED
Trial details
- NCT number
- NCT04896541
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-16
- Primary completion
- 2022-06-14
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.